Form S-3ASR Royalty Pharma plc
http://archive.fast-edgar.com/20240603/AR2VQ22DZZ2RL9Z222JN2ZYKG992ZZ22N262
Filed on: June 3, 2024
Form DEFA14A LL Flooring Holdings,
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
(Amendment No. )
Filed by the Registrant ☒
Filed by a Party other than the Registrant ☐
Check the appropriate box:
☐
Preliminary Proxy Statement
☐
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
☐
Form 4 ARTIVION, INC. For: May 30 Filed by: Salveson Jon W
.FormData {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
}
.FormDataR {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
text-align: right;
}
.SmallFormData {
color: blue;
background-color: white;
font-size: 10px;
font-family: Times, serif;
}
.FootnoteData {
color: green;
background-color: white;
... (continue reading...)
Form 4 aTYR PHARMA INC For: May 31 Filed by: Broadfoot Jill Marie
.FormData {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
}
.FormDataR {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
text-align: right;
}
.SmallFormData {
color: blue;
background-color: white;
font-size: 10px;
font-family: Times, serif;
}
.FootnoteData {
color: green;
background-color: white;
... (continue reading...)
Form 4 ARTIVION, INC. For: May 30 Filed by: Bullock James
.FormData {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
}
.FormDataR {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
text-align: right;
}
.SmallFormData {
color: blue;
background-color: white;
font-size: 10px;
font-family: Times, serif;
}
.FootnoteData {
color: green;
background-color: white;
... (continue reading...)
More SEC Filings
View Older Stories-
Form 8-K Spirit Airlines, Inc. For: May 29
-
Form DEFA14A LL Flooring Holdings,
-
Form 4 aTYR PHARMA INC For: May 31 Filed by: Shukla Sanjay
-
Form 4 ARTIVION, INC. For: May 30 Filed by: Burbank Jeffrey H
-
Form 8-K NorthWestern Energy Grou For: Jun 03
-
Form 8-K GERMAN AMERICAN BANCORP, For: Jun 03
-
Form PREC14A MASIMO CORP Filed by: Politan Capital Management LP
-
Form DEFA14A Match Group, Inc.
-
Form 253G2 Fundrise Equity REIT,
-
Form 424B2 METLIFE INC
-
Form 8-K Match Group, Inc. For: Jun 02
-
Form 8-K HERTZ CORP For: May 29 Filed by: HERTZ GLOBAL HOLDINGS, INC
-
Form 8-K IRADIMED CORP For: May 29
-
Form 1-U Fundrise Equity REIT, For: Jun 01
-
Form 6-K Maris Tech Ltd. For: Jun 03
-
Form 6-K Evaxion Biotech A/S For: Jun 03
-
Form 4 ARTIVION, INC. For: May 30 Filed by: Borgstrom Marna P
-
Form D TO-0411 Gaingels Fund
-
Form 424B2 BURLINGTON NORTHERN SANT
-
Form 1-U FUNDRISE BALANCED EREIT For: Jun 01
-
Form 144 monday.com Ltd. Filed by: Nawi Shiran
-
Form 4 ARTIVION, INC. For: May 30 Filed by: SEMEDO ANTHONY B.
-
Form 1-U Fundrise Midland Opportu For: Jun 01
-
Form 4 ARTIVION, INC. For: May 30 Filed by: Hoff Elizabeth A
-
Form 1-U Fundrise East Coast Oppo For: Jun 01
-
Form 8-K Microbot Medical Inc. For: Jun 03
-
Form 1-U Fundrise West Coast Oppo For: Jun 01
-
Form N-CSRS IVY FUNDS For: Mar 31
-
Form 6-K HONDA MOTOR CO LTD For: Jun 03
-
Form 8-K Arcus Biosciences, Inc. For: Jun 02
-
Form 8-K FTAI Aviation Ltd. For: Jun 03
-
Form 10-12B/A GRAIL, LLC
-
Form FWP CANADIAN IMPERIAL BANK Filed by: CANADIAN IMPERIAL BANK OF COMMERCE /CAN/
-
Form N-CSRS DELAWARE GROUP EQUITY For: Mar 31
-
Form 497K T. Rowe Price Internatio
-
Form 497J EA Series Trust
-
Form 497 T. Rowe Price Internatio
-
Form 8-K OMEGA HEALTHCARE INVESTO For: Jun 03
-
Form SC 13G/A Sky Harbour Group Corp Filed by: Altai Capital Management, L.P.
-
Form 8-K Molecular Templates, For: Jun 03
-
Form 8-K V2X, Inc. For: May 30
-
Form 3 AUTOLIV INC For: Jun 01 Filed by: Olsson Staffan
-
Form 8-K Cullinan Therapeutics, For: Jun 01
-
Form 8-K MCKESSON CORP For: May 28
-
Form 8-K TRANSACT TECHNOLOGIES For: Jun 03
-
Form 8-K CRISPR Therapeutics AG For: May 30
-
Form 8-K 23andMe Holding Co. For: Jun 03
-
Form DEFA14A Synchrony Financial
-
Form 6-K Enlivex Therapeutics For: Jun 03
-
Form 8-K Tonix Pharmaceuticals For: Jun 03